October 2016


Content of this newsletter

- ISPOR: highlighted activities
- Selection of HTA publications online since the summer
- Collaboration with Karolinska Institutet
- EuroQoL meeting Berlin: Improved DCE's, EQ-5D respiratory bolt-on, and patient preferences
- PhD dissertations: Last dissertations of the year on real world evidence and Pompe disease

ISPOR Vienna is coming!

5 iMTA posters have been nominated for the 'Best Poster' award. Drop by to talk research at booth #802 with one of 17 members of iMTA staff who are attending ISPOR. 

View all our presentations and posters here.

Highlighted iMTA presence:

- Issue panel: Should HTA guidelines recommend inclusion of future medical costs? (Pieter van Baal, Alec Morton, Andy Briggs, Ad Antonisse)
- Workshop: Economic Outcomes Research, model verification protocol (Nasuh Buykkaramikli, Maiwenn Al, Dawn Lee, Rachid Raffia). 
- Use of data-mining to perform a real world cost-effectiveness analysis of HER2-positive breast cancer in Iran (Amir Ansaripour)

Highlighted publications

Please find below a selection of peer-reviewed publications online since August:

- Margreet Franken et al on the limited impact of HTA in 4 european countries (Value in Health)
- Morton et al on including future medical costs in NICE guidelines (Health Economics) 
- Maria Gheorghe et al on Bayesian methods to estimate health losses at the end of life (Journal of the Royal Statistical Society)
- Editorial on the new Dutch guidelines for economic evaluations (Pharmacoeconomics)
- Versteegh & Brouwer on including patient preferences in guidelines (SS&M)


Collaboration iMTA - Karolinska Institutet

Thanks to a research grant of the EuroQoL research foundation, iMTA and Karolinska Institutet will start a collaboration on the improvement of quality of life measurement for use in economic evaluations. The research is focused on issues in measuring experienced based health. The team will consist of Dr Kristina Burstrom, Dr Emelie Heintz, Dr Arthur Attema and Dr Matthijs Versteegh.

EuroQoL Plenary Berlin 2016

Each year, the EuroQoL research foundation (founders of EQ-5D instrument) hold an international meeting where members and non-members can discuss state of the art in quality of life research. Marcel Jonker, Martine Hoogendoorn-Lips and Matthijs Versteegh had their papers discussed during the 33rd EuroQoL plenary in Berlin, past september. Marcel Jonker and colleagues improved consistency in discrete choice tasks with attribute overlap and color coding. Martine Hoogendoorn-Lips and colleagues aim to improve the sensitivity of the EQ-5D-5L by adding a respiratory specific dimension. Matthijs Versteegh presented why he and prof Brouwer feel that general public and patient valuations are both valid and can be used in economic evaluations.

PhD dissertations

Saskia de Groot. Evidence from clinical practice to support healthcare decision making. November 10th 2016. 11:30

Tim Kanters. Health Technology Assessment of Orphan Drugs: the example of Pompe disease. December 8th 2016. 11:30

Defended in 2016
Sofie Wouters: Absolutely Relative: on the value of health outcomes.
Maria Gheorghe: Quantitative approaches in monitoring population quality of life.
David Rappange: Future Health: a policy and individual perspective.
Liesbet Lawerman-van de Wetering: Valuing and refining health outcome measures for economic evaluations in health care.
Leander Buisman: Early cost-effectiveness of medical tests in rheumatoid arthritis and ischemic stroke.

iMTA App

Curious to see what iMTA does and see some of the highlights that we have been working on for the past years? We developed the iMTA app in honour of our 25-year existence. Download the iMTA app on your iPAD by linking to the itunes store here




Copyright © 2016 Institute for Medical Technology Assessment, All rights reserved.
Email Marketing Powered by Mailchimp